Mint Tower Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Mint Tower Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,734	Closed	-$374K	–	350
2023 Q2	$374K	Buy	+9,734	New	+$250K	0.04%	158

Mint Tower Capital Management's KDNY Position: Q3 2023 in Review

Mint Tower Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 9,734 shares — an estimated $374K sold.

Mint Tower Capital Management first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $374K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Mint Tower Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Mint Tower Capital Management sold 9,734 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $374K.
Mint Tower Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Mint Tower Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $374K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Mint Tower Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.